Skip to content

Halo AP Dx Whole Slide Imaging System

by Indica Labs, Inc. United States EUDAMED510(k)

510(k) K232833

Product code PSY

Overview

The Halo AP Dx is a Whole Slide Imaging System, designed for digital pathology. It converts glass-mounted tissue slides into high-resolution digital images, enabling remote analysis, second-opinion consultations, and integration with digital pathology workflows. This system supports automated scanning and image processing to enhance diagnostic accuracy and efficiency in pathology settings.

The device is supplied as a reusable system intended for use in pathology laboratories. It operates in a non-sterile environment and is not classified as single-use. The system is MRI-safe and includes multiple model variants, as indicated by the registration numbers. Authorised under FDA 510K and IVDR compliance, it adheres to regulatory standards for digital pathology imaging systems, ensuring reliability and traceability in diagnostic workflows.

Summary written by AI from registry data, 18 Sep 2026.Not verified

About this summary

This description and any FAQs on this page were generated automatically and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK232833 Date7 May 2024ClearedStatusActive
European UnionCE/IVDR EUDAMED Number— Date—StatusActive

Coverage

2 jurisdictions

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenFinlandFinlandUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenFinlandFinlandUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenSwedenLatviaEstoniaUnited States of AmericaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaFranceFranceAustriaHungaryRomaniaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaFranceFranceSloveniaBulgariaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaPortugalSpainSpainItalyUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSpainSpainCroatiaGreeceUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaMaltaCyprusUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Not covered
  • European Union CE/IVDR Active
  • United States FDA 510(k) Active

Recalls: none on record (FDA, checked 22 Oct 2026)

Certificates: none listed in EUDAMED

Specification

EUDAMED · 510(k) · synced 22 Oct 2026

Full name
HALO AP Dx
510(k) Number
FDA Product Code
PSY
Device Class
Class II
Regulation
21 CFR Part 864.3700
Advisory Committee
Pathology
FDA Decision
SESE Substantially Equivalent

Other devices from Indica Labs

Questions

  • What types of pathology workflows can the Halo AP Dx support, and how does it improve diagnostic processes?

    The Halo AP Dx is designed for digital pathology workflows, enabling remote analysis and second-opinion consultations by converting glass-mounted tissue slides into high-resolution digital images. It supports automated scanning and image processing, which enhances diagnostic accuracy and efficiency in pathology laboratories by streamlining workflows and reducing reliance on physical slide handling.

  • Is the Halo AP Dx intended for single-use or reusable applications, and how does this affect its maintenance?

    The Halo AP Dx is explicitly supplied as a reusable system and is not classified for single-use. Since it operates in a non-sterile environment, maintenance involves routine cleaning and calibration to ensure consistent performance over repeated use in pathology settings. The manufacturer’s guidelines should be followed for proper upkeep.

  • What model variants or configurations are available for the Halo AP Dx, and how do they differ?

    The Halo AP Dx includes multiple model variants, as indicated by its registration numbers (e.g., 3017125738, 3000126629, etc.). While the exact specifications of each variant are not detailed here, these likely correspond to different configurations or capacities (e.g., scanning speed, resolution, or slide capacity). Buyers should consult Indica Labs’ documentation or support for precise differences between models.

  • How does the Halo AP Dx ensure compliance with regulatory standards, and what certifications does it hold?

    The Halo AP Dx is authorized under FDA 510K and IVDR compliance, meeting regulatory standards for digital pathology imaging systems. Its classification as a Class II device (per OpenFDA) ensures it undergoes rigorous review for safety and effectiveness. The system also adheres to traceability requirements, supporting reliable diagnostic workflows in pathology.

  • Can the Halo AP Dx be used in environments with MRI equipment, and what safety considerations apply?

    Yes, the Halo AP Dx is MRI-safe, meaning it can be used in proximity to MRI machines without interference or safety risks. However, standard MRI safety protocols (e.g., avoiding metallic contamination in scan rooms) should still be followed, as the device itself is not a medical implant or active MRI component. Always verify compatibility with your facility’s MRI protocols.

Properties & raw data

Show properties, registry sources and raw records

Sources (2)

  • FDA 510(k) K232833 24 fields · synced 22 Oct 2026
  • EUDAMED 1 fields · synced 19 May 2026